<DOC>
	<DOCNO>NCT02145104</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety cilinidipine plus valsartan valsartan alone patient essential hypertension inadequately control valsartan monotherapy</brief_summary>
	<brief_title>Efficacy/Safety Cilnidipine Plus Valsartan Versus Valsartan Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Cilnidipine</mesh_term>
	<criteria>essential hypertension patient whose blood pressure control study ( sDBP≥90mmHg drugtreated patient , sDBP≥95mmHg drugnaive patient ) sSBP≥80mmHg 4weeks valsartan 160mg treatment history hypersensitivity dihydropyridines angiotensin II receptor blocker</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>